LeMaitre Vascular
LMAT
339 hedge funds and large institutions have $2.41B invested in LeMaitre Vascular in 2026 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 121 increasing their positions, 101 reducing their positions, and 24 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
196% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 24
40% more capital invested
Capital invested by funds: $1.73B → $2.41B (+$686M)
20% more repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 101
14% more funds holding
Funds holding: 297 → 339 (+42)
3.23% more ownership
Funds ownership: 93.93% → 97.16% (+3.2%)
50% less call options, than puts
Call options by funds: $393K | Put options by funds: $786K
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$20.8M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$18.8M |
| 3 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$14.4M |
| 4 |
Two Sigma Investments
New York
|
+$13.2M |
| 5 |
Bessemer Group
Woodbridge,
New Jersey
|
+$12.2M |
Top Sellers
LMAT Hedge Fund Activity: Q1 2026 in Review
339 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q1 2026, worth a combined $2.41B — up 40% from $1.73B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new LMAT positions and 24 closed out — a net gain of 47 holders — while 121 added to existing stakes and 101 trimmed.
The largest buyer was Invesco, adding an estimated $20.8M. The largest seller was Ranger Investment Management, cutting an estimated $13.2M.
- 339 institutional investors held LeMaitre Vascular (LMAT) as of Q1 2026, up from 297 in Q4 2025.
- Funds reported $2.41B of LeMaitre Vascular stock for Q1 2026, up 40% quarter-over-quarter.
- 71 funds opened new LeMaitre Vascular positions in Q1 2026 and 24 closed out, a net change of +47 holders.
- The largest LeMaitre Vascular buyer in Q1 2026 was Invesco, an estimated $20.8M added.
- The largest LeMaitre Vascular seller in Q1 2026 was Ranger Investment Management, an estimated $13.2M sold.
Based on aggregated 13F filings for Q1 2026.